المؤلفون: Burgess P., Morphet J., Nou S., Russo P., Sarson M., Young A., Norris S., Morris-Donovan B., Gurry S., Hudson E., Hurley S., Primmer D., Timms S., Whicker S., Mukherjee S., Booth K., Cameron P., Cooper M., Cheng A., Fowler P., Frydenberg M., McGloughlin S., McPhee E., Mitchell B., O'Donnell C., Parr M., Phillips J., Varndell W., Whyte I., Randall R., Brightwell R., Condon L., Deshpande A., Ehm A., Ferrie M., Muller J., Pullin L., Robinson E., Witt A., Larkins S., Morgan M., Taylor G., Agostino J., Douglas K., Ewald B., Fornasier D., Knight S., Nelson C., Peachey L., Peiris D., Driel M., Walters L., Weaver I., Burr L., Hendel S., Shekar K., Avard B., Cairns K., Glanville A., Gilroy N., Myles P., O'Sullivan R., Robinson O., Sharland C., McCarthy S., Wark P., McGoughlin S., Hodgson C., Ankravs M., Hansen K., Huckson S., Iredell J., Janerka C., Jaspers R., Litton E., Macdonald S., Peake S., Bowen A., McMullan B., Tingay D., Vasilunas N., Anderson L., Best J., Burns P., Erickson S., Fancourt N., Goff Z., Kapuya V., Keyte C., Malyon L., Wurzel D., Agar M., Lindley R., Smallwood N., Callary M., Chapman M., Good P., Jenkin P., Morgan D., Naganathan V., Srikanth V., Tuffin P., Whiting E., William L., Yates P., Barber B., Davies J., Davis J., Gwee A., Leder K., Matthews G., McMahon J., Peel T., Raftery C., Rees M., Roberts J., Seppelt I., Wibrow B., Baker R., Curnow J., Cutts B., Enjeti A., Forbes A., Ho P., Holyoak A., Liley H., McFadyen J., McQuilten Z., Merriman E., Savoia H., Tan C.W., Tran H., Ward C., Williams K., Ballard N., Bendall S., Bhanderi N., Byers L., Craig S., Ellis D., Ewald D., Fairley C., Hoggard B., Cong M.L., Morley P., Nair P., Pearce A., Turner T., Callesen H., Campbell S., Ring J., Wilson A., Henry D., Pearson S., Boyle D., Chidwick K., Chapman W., French C., Pearce C., Snelling T., Bero L., Grundy Q., Lexchin J., Mintzes B., Vogel J.P., Tendal B., Giles M., Whitehead C., Burton W., Chakraborty S., Cheyne S., Downton T., Fraile Navarro D., Gleeson G., Gordon A., Hunt J., Kitschke J., McDonald S., McDonnell N., Middleton P., Millard T., Murano M., Oats J., Tate R., White H., Elliott J., Roach V., Homer C.S.E., McGowan S., Ballenden N., Barrett T.-L., Beavis V., Saunders J.B., Buchanan T., Buchanan-Grey M., Casey D., Cowie M., Doyle J., Gnjidic D., Green S., Greenland R., Griffin K., Groombridge S., Hardy L., Hodak A., Holley A., Jovanovska V., Michaels K.

مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655
Australian and New Zealand Journal of Obstetrics and Gynaecology
Click here for full text options
LibKey Link

المؤلفون: Burgess P., Morphet J., Nou S., Russo P., Sarson M., Young A., Norris S., Morris-Donovan B., Gurry S., Hudson E., Hurley S., Primmer D., Timms S., Whicker S., Mukherjee S., Booth K., Cameron P., Cooper M., Cheng A., Fowler P., Frydenberg M., McGloughlin S., McPhee E., Mitchell B., O'Donnell C., Parr M., Phillips J., Varndell W., Whyte I., Randall R., Brightwell R., Condon L., Deshpande A., Ehm A., Ferrie M., Muller J., Pullin L., Robinson E., Witt A., Larkins S., Morgan M., Taylor G., Agostino J., Douglas K., Ewald B., Fornasier D., Knight S., Nelson C., Peachey L., Peiris D., Driel M., Walters L., Weaver I., Burr L., Hendel S., Shekar K., Avard B., Cairns K., Glanville A., Gilroy N., Myles P., O'Sullivan R., Robinson O., Sharland C., McCarthy S., Wark P., McGoughlin S., Hodgson C., Ankravs M., Hansen K., Huckson S., Iredell J., Janerka C., Jaspers R., Litton E., Macdonald S., Peake S., Bowen A., McMullan B., Tingay D., Vasilunas N., Anderson L., Best J., Burns P., Erickson S., Fancourt N., Goff Z., Kapuya V., Keyte C., Malyon L., Wurzel D., Agar M., Lindley R., Smallwood N., Callary M., Chapman M., Good P., Jenkin P., Morgan D., Naganathan V., Srikanth V., Tuffin P., Whiting E., William L., Yates P., Barber B., Davies J., Davis J., Gwee A., Leder K., Matthews G., McMahon J., Peel T., Raftery C., Rees M., Roberts J., Seppelt I., Wibrow B., Baker R., Curnow J., Cutts B., Enjeti A., Forbes A., Ho P., Holyoak A., Liley H., McFadyen J., McQuilten Z., Merriman E., Savoia H., Tan C.W., Tran H., Ward C., Williams K., Ballard N., Bendall S., Bhanderi N., Byers L., Craig S., Ellis D., Ewald D., Fairley C., Hoggard B., Cong M.L., Morley P., Nair P., Pearce A., Turner T., Callesen H., Campbell S., Ring J., Wilson A., Henry D., Pearson S., Boyle D., Chidwick K., Chapman W., French C., Pearce C., Snelling T., Bero L., Grundy Q., Lexchin J., Mintzes B., Vogel J.P., Tendal B., Giles M., Whitehead C., Burton W., Chakraborty S., Cheyne S., Downton T., Fraile Navarro D., Gleeson G., Gordon A., Hunt J., Kitschke J., McDonald S., McDonnell N., Middleton P., Millard T., Murano M., Oats J., Tate R., White H., Elliott J., Roach V., Homer C.S.E., McGowan S., Ballenden N., Barrett T.-L., Beavis V., Saunders J.B., Buchanan T., Buchanan-Grey M., Casey D., Cowie M., Doyle J., Gnjidic D., Green S., Greenland R., Griffin K., Groombridge S., Hardy L., Hodak A., Holley A., Jovanovska V., Michaels K.

مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655
Australian and New Zealand Journal of Obstetrics and Gynaecology
LibKey Link

المؤلفون: Chow C.K., Wong S., Lund M., Chew D.P., Kritharides L., Bhindi R., Zaman S., MacIsaac A.I., Jennings G.L.R., Schlaich M.P., Inglis S.C., Arnold R., Kumar S., Thomas L., Wahi S., Lo S., Naismith C., Duffy S.J., Nicholls S.J., Newcomb A., Almeida A.A.

مصطلحات الفهرس: exercise test, health care personnel, health service, heart electrophysiology, heart infarction, heart injury, heart pacing, human, New Zealand, nonhuman, pandemic, community care, coronary angiography, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/ep [Epidemiology], troponin/ec [Endogenous Compound], article, Australia, cardiac imaging, cardiovascular disease/di [Diagnosis], cardiovascular disease/dt [Drug Therapy], cardiovascular disease/su [Surgery], cardiovascular disease/th [Therapy], consensus, primary medical care, resuscitation, Severe acute respiratory syndrome coronavirus 2, telehealth, thorax surgery, transesophageal echocardiography, transthoracic echocardiography, angiotensin receptor antagonist/dt [Drug Therapy], azithromycin/dt [Drug Therapy], chloroquine/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], lopinavir plus ritonavir/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29181
Medical Journal of Australia
Click here for full text options
LibKey Link

المؤلفون: Wong A.

مصطلحات الفهرس: bone marrow suppression/si [Side Effect], China, coma/si [Side Effect], convulsion/si [Side Effect], coronavirus disease 2019/dt [Drug Therapy], diarrhea/si [Side Effect], drug efficacy, drug overdose, drug research, evidence based medicine, gastrointestinal symptom/si [Side Effect], headache/si [Side Effect], heart arrhythmia/si [Side Effect], human, hypertransaminasemia/si [Side Effect], hypokalemia/si [Side Effect], hypotension/si [Side Effect], kidney dysfunction/si [Side Effect], liver injury/si [Side Effect], morbidity, mortality, nonhuman, pancreatitis/si [Side Effect], pandemic, patient safety, priority journal, QT prolongation/si [Side Effect], rash/si [Side Effect], self medication, treatment outcome, virus load, virus transmission, activated carbon/dt [Drug Therapy], azithromycin/ae [Adverse Drug Reaction], drug intoxication/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], ceftriaxone/cb [Drug Combination], ceftriaxone/dt [Drug Therapy], ceftriaxone/pv [Special Situation for Pharmacovigilance], chloroquine/ae [Adverse Drug Reaction], chloroquine/cb [Drug Combination], chloroquine/do [Drug Dose], chloroquine/dt [Drug Therapy], article, atrioventricular block/si [Side Effect], bleeding/si [Side Effect], chloroquine/pv [Special Situation for Pharmacovigilance], colchicine/do [Drug Dose], colchicine/dt [Drug Therapy], colchicine/to [Drug Toxicity], colchicine/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/do [Drug Dose], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pv [Special Situation for Pharmacovigilance], ivermectin/do [Drug Dose], ivermectin/dt [Drug Therapy], ivermectin/to [Drug Toxicity], lopinavir plus ritonavir/ae [Adverse Drug Reaction], lopinavir plus ritonavir/do [Drug Dose], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/to [Drug Toxicity], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], remdesivir/ae [Adverse Drug Reaction], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], thalidomide/do [Drug Dose], thalidomide/dt [Drug Therapy], thalidomide/to [Drug Toxicity], thalidomide/pv [Special Situation for Pharmacovigilance], tocilizumab/ae [Adverse Drug Reaction], tocilizumab/dt [Drug Therapy], tocilizumab/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29200
EMA - Emergency Medicine Australasia
Click here for full text options
LibKey Link

المؤلفون: Chow C.K., Wong S., Lund M., Chew D.P., Kritharides L., Bhindi R., Zaman S., MacIsaac A.I., Jennings G.L.R., Schlaich M.P., Inglis S.C., Arnold R., Kumar S., Thomas L., Wahi S., Lo S., Naismith C., Duffy S.J., Nicholls S.J., Newcomb A., Almeida A.A.

مصطلحات الفهرس: exercise test, health care personnel, health service, heart electrophysiology, heart infarction, heart injury, heart pacing, human, New Zealand, nonhuman, pandemic, community care, coronary angiography, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/ep [Epidemiology], troponin/ec [Endogenous Compound], article, Australia, cardiac imaging, cardiovascular disease/di [Diagnosis], cardiovascular disease/dt [Drug Therapy], cardiovascular disease/su [Surgery], cardiovascular disease/th [Therapy], consensus, primary medical care, resuscitation, Severe acute respiratory syndrome coronavirus 2, telehealth, thorax surgery, transesophageal echocardiography, transthoracic echocardiography, angiotensin receptor antagonist/dt [Drug Therapy], azithromycin/dt [Drug Therapy], chloroquine/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], lopinavir plus ritonavir/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29181
Medical Journal of Australia
LibKey Link

المؤلفون: Wong A.

مصطلحات الفهرس: bone marrow suppression/si [Side Effect], China, coma/si [Side Effect], convulsion/si [Side Effect], coronavirus disease 2019/dt [Drug Therapy], diarrhea/si [Side Effect], drug efficacy, drug overdose, drug research, evidence based medicine, gastrointestinal symptom/si [Side Effect], headache/si [Side Effect], heart arrhythmia/si [Side Effect], human, hypertransaminasemia/si [Side Effect], hypokalemia/si [Side Effect], hypotension/si [Side Effect], kidney dysfunction/si [Side Effect], liver injury/si [Side Effect], morbidity, mortality, nonhuman, pancreatitis/si [Side Effect], pandemic, patient safety, priority journal, QT prolongation/si [Side Effect], rash/si [Side Effect], self medication, treatment outcome, virus load, virus transmission, activated carbon/dt [Drug Therapy], azithromycin/ae [Adverse Drug Reaction], drug intoxication/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], ceftriaxone/cb [Drug Combination], ceftriaxone/dt [Drug Therapy], ceftriaxone/pv [Special Situation for Pharmacovigilance], chloroquine/ae [Adverse Drug Reaction], chloroquine/cb [Drug Combination], chloroquine/do [Drug Dose], chloroquine/dt [Drug Therapy], article, atrioventricular block/si [Side Effect], bleeding/si [Side Effect], chloroquine/pv [Special Situation for Pharmacovigilance], colchicine/do [Drug Dose], colchicine/dt [Drug Therapy], colchicine/to [Drug Toxicity], colchicine/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/do [Drug Dose], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pv [Special Situation for Pharmacovigilance], ivermectin/do [Drug Dose], ivermectin/dt [Drug Therapy], ivermectin/to [Drug Toxicity], lopinavir plus ritonavir/ae [Adverse Drug Reaction], lopinavir plus ritonavir/do [Drug Dose], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/to [Drug Toxicity], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], remdesivir/ae [Adverse Drug Reaction], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], thalidomide/do [Drug Dose], thalidomide/dt [Drug Therapy], thalidomide/to [Drug Toxicity], thalidomide/pv [Special Situation for Pharmacovigilance], tocilizumab/ae [Adverse Drug Reaction], tocilizumab/dt [Drug Therapy], tocilizumab/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29200
EMA - Emergency Medicine Australasia
LibKey Link

المؤلفون: David B., Steer A.C., Ladhani S., Shingadia D., Bryant P.A., Kiang K.M.

مصطلحات الفهرس: nonhuman, outpatient care, overall survival, Plasmodium knowlesi malaria/dt [Drug Therapy], Plasmodium ovale malaria/dt [Drug Therapy], Plasmodium vivax malaria/dt [Drug Therapy], priority journal, review, arteether/im [Intramuscular Drug Administration], arteether/po [Oral Drug Administration], arteether/pa [Parenteral Drug Administration], artemether/dt [Drug Therapy], artemether plus benflumetol/dt [Drug Therapy], artemether plus benflumetol/po [Oral Drug Administration], artemisinin/dt [Drug Therapy], artesunate/cb [Drug Combination], artesunate/dt [Drug Therapy], artesunate/im [Intramuscular Drug Administration], artesunate/iv [Intravenous Drug Administration], artesunate/po [Oral Drug Administration], artesunate/pa [Parenteral Drug Administration], artesunate plus mefloquine, artesunate plus pyronaridine, atovaquone plus proguanil/dt [Drug Therapy], atovaquone plus proguanil/po [Oral Drug Administration], chloroquine/dt [Drug Therapy], chloroquine plus primaquine/dt [Drug Therapy], dihydroartemisinin/dt [Drug Therapy], dihydroartemisinin plus piperaquine, mefloquine/dt [Drug Therapy], mefloquine/po [Oral Drug Administration], piperaquine/dt [Drug Therapy], piperaquine/po [Oral Drug Administration], primaquine/dt [Drug Therapy], pyrimethamine plus sulfadoxine/cb [Drug Combination], pyrimethamine plus sulfadoxine/dt [Drug Therapy], pyrimethamine plus sulfadoxine/po [Oral Drug Administration], pyronaridine/dt [Drug Therapy], quinine/dt [Drug Therapy], quinine/iv [Intravenous Drug Administration], unclassified drug, amatem, arsucam, coarsucam, coartem d, cotecxin, faverid, lonart, winthrop, human, amodiaquine/dt [Drug Therapy], amodiaquine/po [Oral Drug Administration], arteether/dt [Drug Therapy], antimicrobial therapy, childhood disease/dt [Drug Therapy], childhood mortality, combination chemotherapy, disease severity, drug efficacy, drug treatment failure, drug utilization, gametocyte, loading drug dose, malaria/dt [Drug Therapy], malaria falciparum/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27517
Click here for full text options
LibKey Link

المؤلفون: David B., Steer A.C., Ladhani S., Shingadia D., Bryant P.A., Kiang K.M.

مصطلحات الفهرس: nonhuman, outpatient care, overall survival, Plasmodium knowlesi malaria/dt [Drug Therapy], Plasmodium ovale malaria/dt [Drug Therapy], Plasmodium vivax malaria/dt [Drug Therapy], priority journal, review, arteether/im [Intramuscular Drug Administration], arteether/po [Oral Drug Administration], arteether/pa [Parenteral Drug Administration], artemether/dt [Drug Therapy], artemether plus benflumetol/dt [Drug Therapy], artemether plus benflumetol/po [Oral Drug Administration], artemisinin/dt [Drug Therapy], artesunate/cb [Drug Combination], artesunate/dt [Drug Therapy], artesunate/im [Intramuscular Drug Administration], artesunate/iv [Intravenous Drug Administration], artesunate/po [Oral Drug Administration], artesunate/pa [Parenteral Drug Administration], artesunate plus mefloquine, artesunate plus pyronaridine, atovaquone plus proguanil/dt [Drug Therapy], atovaquone plus proguanil/po [Oral Drug Administration], chloroquine/dt [Drug Therapy], chloroquine plus primaquine/dt [Drug Therapy], dihydroartemisinin/dt [Drug Therapy], dihydroartemisinin plus piperaquine, mefloquine/dt [Drug Therapy], mefloquine/po [Oral Drug Administration], piperaquine/dt [Drug Therapy], piperaquine/po [Oral Drug Administration], primaquine/dt [Drug Therapy], pyrimethamine plus sulfadoxine/cb [Drug Combination], pyrimethamine plus sulfadoxine/dt [Drug Therapy], pyrimethamine plus sulfadoxine/po [Oral Drug Administration], pyronaridine/dt [Drug Therapy], quinine/dt [Drug Therapy], quinine/iv [Intravenous Drug Administration], unclassified drug, amatem, arsucam, coarsucam, coartem d, cotecxin, faverid, lonart, winthrop, human, amodiaquine/dt [Drug Therapy], amodiaquine/po [Oral Drug Administration], arteether/dt [Drug Therapy], antimicrobial therapy, childhood disease/dt [Drug Therapy], childhood mortality, combination chemotherapy, disease severity, drug efficacy, drug treatment failure, drug utilization, gametocyte, loading drug dose, malaria/dt [Drug Therapy], malaria falciparum/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27517
LibKey Link

المؤلفون: Woolley I., Horne K.

مصطلحات الفهرس: antimalarial agent/dt [Drug Therapy], chemokine receptor/ec [Endogenous Compound], chemokine receptor CCR5 antagonist/dt [Drug Therapy], chloroquine/dt [Drug Therapy], Duffy binding protein/ec [Endogenous Compound], maraviroc/dt [Drug Therapy], unclassified drug, vicriviroc/dt [Drug Therapy], Duffy antigen chemokine receptor/ec [Endogenous Compound], mortality, article, drug design, drug targeting, erythrocyte, gene mutation, host pathogen interaction, human, Human immunodeficiency virus infection/dt [Drug Therapy], malaria/dt [Drug Therapy], mixed infection, nonhuman, Plasmodium falciparum, Plasmodium vivax, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28225
LibKey Link

المؤلفون: Smith A., Shortt J., Spelman D., Denholm J.

مصطلحات الفهرس: malaria falciparum/di [Diagnosis], malaria falciparum/dt [Drug Therapy], male, mixed infection/dt [Drug Therapy], mixed infection/di [Diagnosis], parasite identification, patient compliance, Plasmodium malariae infection/dt [Drug Therapy], priority journal, rigor, travel, Uganda, artemether plus benflumetol/dt [Drug Therapy], chloroquine/dt [Drug Therapy], doxycycline/cb [Drug Combination], doxycycline/dt [Drug Therapy], doxycycline/po [Oral Drug Administration], quinine sulfate/cb [Drug Combination], quinine sulfate/dt [Drug Therapy], quinine sulfate/po [Oral Drug Administration], Plasmodium malariae infection/di [Diagnosis], adult, article, case report, chemoprophylaxis, combination chemotherapy, drug response, drug substitution, drug treatment failure, drug withdrawal, fever, headache, human, lethargy, malaise, malaria/dt [Drug Therapy], malaria/pc [Prevention], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30162
Click here for full text options
LibKey Link

المؤلفون: Smith A., Shortt J., Spelman D., Denholm J.

مصطلحات الفهرس: malaria falciparum/di [Diagnosis], malaria falciparum/dt [Drug Therapy], male, mixed infection/dt [Drug Therapy], mixed infection/di [Diagnosis], parasite identification, patient compliance, Plasmodium malariae infection/dt [Drug Therapy], priority journal, rigor, travel, Uganda, artemether plus benflumetol/dt [Drug Therapy], chloroquine/dt [Drug Therapy], doxycycline/cb [Drug Combination], doxycycline/dt [Drug Therapy], doxycycline/po [Oral Drug Administration], quinine sulfate/cb [Drug Combination], quinine sulfate/dt [Drug Therapy], quinine sulfate/po [Oral Drug Administration], Plasmodium malariae infection/di [Diagnosis], adult, article, case report, chemoprophylaxis, combination chemotherapy, drug response, drug substitution, drug treatment failure, drug withdrawal, fever, headache, human, lethargy, malaise, malaria/dt [Drug Therapy], malaria/pc [Prevention], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30162
LibKey Link

المؤلفون: Grayson M.L., Turnidge J.D., Munckhof W.J.

مصطلحات الفهرس: Plasmodium vivax, travel, antimalarial agent/dt [Drug Therapy], chloroquine/dt [Drug Therapy], primaquine/dt [Drug Therapy], malaria/dt [Drug Therapy], adult, case report, clinical feature, fever, human, Indonesia, infection risk, letter, malaria/di [Diagnosis], malaria/pc [Prevention], male, mosquito, myalgia, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34101
Medical Journal of Australia
Click here for full text options
LibKey Link

المؤلفون: Grayson M.L., Turnidge J.D., Munckhof W.J.

مصطلحات الفهرس: Plasmodium vivax, travel, antimalarial agent/dt [Drug Therapy], chloroquine/dt [Drug Therapy], primaquine/dt [Drug Therapy], malaria/dt [Drug Therapy], adult, case report, clinical feature, fever, human, Indonesia, infection risk, letter, malaria/di [Diagnosis], malaria/pc [Prevention], male, mosquito, myalgia, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34101
Medical Journal of Australia
Click here for full text options
LibKey Link